- Clinical applications of functional imaging in oncology
- Fusion imaging: positron emission tomography, computed tomography, magnetic resonance imaging
- Novel radiopharmaceuticals targeting tumors
- Metabolic response assessment to therapy
Radiother Oncol. 2019 Mar 19;135:107-114
Utility of 18F-FDG-PET/CT imaging in patients with recurrent gynecological malignancies prior to pelvic exenteration.
Int J Gynecol Cancer. 2019 Mar 28;:
The contribution of multiparametric pelvic & whole body MR to interpretation of 18F-fluoromethylcholine or 68Ga-HBED-CC PSMA-11 PET/CT in patients with biochemical failure following radical prostatectomy.
J Nucl Med. 2019 Mar 22;:
Applying Radiomics to Predict Pathology of Postchemotherapy Retroperitoneal Nodal Masses in Germ Cell Tumors.
JCO Clin Cancer Inform. 2018 Dec;(2):1-12
Effect of Positron Emission Tomography Imaging in Women With Locally Advanced Cervical Cancer: A Randomized Clinical Trial.
JAMA Netw Open. 2018 Sep 07;1(5):e182081
Effect of PET/CT on the Management and Outcomes of Participants with Hodgkin and Aggressive Non-Hodgkin Lymphoma: A Multicenter Registry.
Radiology. 2018 Dec 04;:181519
A Prospective, Multi-site, International Comparison of F-18 fluoro-methyl-choline, multi-parametric magnetic resonance and Ga-68 HBED-CC (PSMA-11) in men with High-Risk Features and Biochemical Failure after Radical Prostatectomy: Clinical Performance...
J Nucl Med. 2018 Nov 15;:
Quantitative assessment of dynamic 18F-Fluoromethycholine PET and Dynamic Contrast Enhanced MRI in High Risk Prostate Cancer.
Br J Radiol. 2018 Nov 01;:20180568
Comparison of MRI Sequences in Whole-Body PET/MRI for Staging of Patients With High-Risk Prostate Cancer.
AJR Am J Roentgenol. 2018 Oct 17;:W1-W5
Clin Nucl Med. 2018 Sep 21;:
Core Lead, Techna Institute for the Advancement of Technology for Health (Techna)
Cancer Clinical Research Unit (CCRU), Princess Margaret Cancer Centre
Associate Professor, Department of Medical Imaging, University of Toronto